Marika Saar, Jana Jaal, Alvin Meltsov, Tõnis Laasfeld, Helen Lust, Sergo Kasvandik, & Darja Lavogina. (2023). Exploring the Molecular Players behind the Potentiation of Chemotherapy Effects by Durvalumab in Lung Adenocarcinoma Cell Lines. MDPI AG.
Chicago Style (17th ed.) CitationMarika Saar, Jana Jaal, Alvin Meltsov, Tõnis Laasfeld, Helen Lust, Sergo Kasvandik, and Darja Lavogina. Exploring the Molecular Players Behind the Potentiation of Chemotherapy Effects by Durvalumab in Lung Adenocarcinoma Cell Lines. MDPI AG, 2023.
MLA (9th ed.) CitationMarika Saar, et al. Exploring the Molecular Players Behind the Potentiation of Chemotherapy Effects by Durvalumab in Lung Adenocarcinoma Cell Lines. MDPI AG, 2023.
Warning: These citations may not always be 100% accurate.